News
-
-
-
PRESS RELEASE
Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid's Emerging Role in Renal Replacement Therapy Decisions
SphingoTec GmbH announces groundbreaking research on using penKid biomarker to assess kidney recovery in post-cardiac surgery patients undergoing CRRT. Study reveals promising outcomes for CRRT liberation decisions -
-
-
-
-
-
PRESS RELEASE
SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers
SphingoTec secures €5M Series C funding led by Think.Health Ventures to drive global expansion and commercialize innovative biomarkers for critical care, aiming for improved patient outcomes -